sulpiride has been researched along with Tachyarrhythmia in 4 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These results suggest that in anaesthetised and conscious normotensive rats, the bromocriptine induced tachycardia is not related to a release of adrenaline from the adrenal medulla but could be elicited by central dopamine D-2 receptor stimulation through a possible increase in cardiac sympathetic tone." | 7.68 | Central dopaminergic origin of bromocriptine induced tachycardia in normotensive rats. ( Demenge, P; Duarte, GP; Lahlou, S, 1993) |
| "These results suggest that in anaesthetised and conscious normotensive rats, the bromocriptine induced tachycardia is not related to a release of adrenaline from the adrenal medulla but could be elicited by central dopamine D-2 receptor stimulation through a possible increase in cardiac sympathetic tone." | 3.68 | Central dopaminergic origin of bromocriptine induced tachycardia in normotensive rats. ( Demenge, P; Duarte, GP; Lahlou, S, 1993) |
| "There was 1 case of torsade de pointes in a thioridazine overdose." | 1.42 | Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram. ( Berling, I; Isbister, GK, 2015) |
| "As part of the FP7 ARITMO (Arrhythmogenic Potential of Drugs) project, we explored the publicly available US FDA Adverse Event Reporting System (FAERS) database to detect signals of torsadogenicity for antipsychotics (APs)." | 1.39 | Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database. ( Behr, ER; De Ponti, F; Koci, A; Moretti, U; Poluzzi, E; Raschi, E; Spina, E; Sturkenboom, M, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Poluzzi, E | 1 |
| Raschi, E | 1 |
| Koci, A | 1 |
| Moretti, U | 1 |
| Spina, E | 1 |
| Behr, ER | 1 |
| Sturkenboom, M | 1 |
| De Ponti, F | 1 |
| Berling, I | 1 |
| Isbister, GK | 1 |
| Lahlou, S | 1 |
| Duarte, GP | 1 |
| Demenge, P | 1 |
| Züchner, H | 1 |
4 other studies available for sulpiride and Tachyarrhythmia
| Article | Year |
|---|---|
Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database.
Topics: Adverse Drug Reaction Reporting Systems; Amisulpride; Antipsychotic Agents; Arrhythmias, Cardiac; Be | 2013 |
Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Drug Overdose; Electrocardiography; Fema | 2015 |
Central dopaminergic origin of bromocriptine induced tachycardia in normotensive rats.
Topics: Adrenalectomy; Animals; Blood Pressure; Bromocriptine; Domperidone; Dopamine D2 Receptor Antagonists | 1993 |
[QT prolongation and torsade de pointes--tachycardia in therapy with maprotiline].
Topics: Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Brain Damage, Chronic; | 2002 |